U.S. federal trademark · Serial No. 78492452 · Reg. No. 3665049
Pharmaceutical products, namely, preparations and substances for the treatment of cancers and immunological diseases and disorders, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas and immunological disorders such as transplant rejection
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.